Knowledge Center
Patent / Jan 01, 1985
.alpha.-Deoxytetracyclines
Source:
EP 137661
.alpha.-Deoxytetracyclines I (R = H, OH) were prepd. stereoselectively by reducing methylenetetracyclines II (R = H, OH; R1 = Br, Cl) and III on an aminopropylsilsesquioxane-supported Rh catalyst in the presence of a triarylphosphine. Thus, III (R = OH) was hydrogenated on RhCl3[N[(CH2)3SiO3/2]3]10 in the presence of PPh3 to give 87.4% doxycycline 99.6% pure.
Also in the Knowledge Center
/ Jan 26, 2023
Webinar - Accelerating the Adoption of Continuous Tableting: The Responsibility of a CDMO
Read more
Scientific Article
/ Feb 22, 2017
Webinar - Development by Design: Hovione’s Approach to Spray Drying Process Development
Read more
Scientific Article
/ Feb 22, 2017
Webinar - Physical Characterization of Drugs: avoiding surprises during late development
Read more
Scientific Article